When it comes to Gaza, Trump is all mouth and no trousers
Remember Donald Trump's vow that there would be 'all hell to pay' if Hamas hadn't released all the hostages by the time he took office? What happened to that? Four months later and for all his tough talk, the president is slumping into a Biden crouch.
His envoy, Steve Witkoff, is poised to unveil a revised Israel-Hamas ceasefire proposal amid optimistic leaks, mainly from sources in the United States, that a larger deal may be in the offing.
This will likely entail the phased release of ten hostages out of the 20 presumed still living, as well as the remains of a further 18. This will leave the jihadis in control of ten living hostages and 20 bodies, which in their depraved eyes amounts to a pretty significant hand of playing cards to keep.
In return, Israel may release 125 notorious murderers with much innocent blood on their hands, not to mention military experience and an undimmed fanaticism in their souls, as well as 1,111 prisoners captured after October 7 and the remains of 180 terrorists killed in battle. The latter is an unusual demand to be emphasised by Hamas, which appears to be mimicking Jewish veneration of the dead. Aid will also be ramped up.
All this will be arranged around a 60-day pause in fighting. The White House seems confident that it has reassured Israel that either the campaign or further hostage negotiations, or both, may be recommenced if the deadline passes with no progress in talks for a final end to hostilities. Israel has reportedly indicated it will accept.
So far, so Joe Biden. For those Trump supporters who were looking forward to seeing Hamas blasted to kingdom come as soon as his feet hit the Oval carpet, it all looks rather flaccid. What happened to his cherished Riviera?
Just like during the Biden era, we have even witnessed an extraordinary propaganda campaign waged by Hamas, the United Nations, a range of NGOs and the international media to obstruct a joint Israeli-American attempt to create a means of delivering aid directly to the people of Gaza while bypassing their jihadi overlords.
As Israel has looked in danger of winning, the disinformation has hit fever pitch. Gaza, we have been told, is on the verge of famine, which quickly elides into claims of an actual famine, despite no evidence of deaths of starvation and plentiful videos on social media of reasonable conditions in the Strip.
This has been accompanied by a plethora of fabricated, exaggerated or just plain fishy claims made by Hamas and magnified by a venomously Israelophobic elite and their radical progressive allies.
The arts world swung into action. R&B musicians 'spoke out' and almost 400 novelists signed a letter pledging to brand Israel's campaign 'genocide'. Odd kind of genocide when the aggressor warns civilians before it attacks, fails for two-and-a-half years to complete the supposed crime despite having the firepower to do so in two-and-a-half hours, and goes out of its way to deliver aid.
If anybody had been paying attention, they would have observed that Israel had been accused of 'genocide' in earnest since October 8, and in general for many decades before that. The fact that the job of a novelist is literally to make up stories was apparently lost upon them.
The disinformation has been as transparent as it has been ubiquitous. Yet following in the footsteps of Joe Biden before him, Trump failed to condemn this wave of lies, instead dignifying it by adding the claim of his own that 'a lot of people are starving' while hanging out with a bunch of Arab leaders.
It doesn't stop there. We had high hopes that Iran would finally meet some serious opposition when the Donald returned to office. After all, this was the man who had authorised the killing of the totemic Iranian major general Qasem Soleimani, king of overseas meddling, in 2020.
Yet just as the time is ripe for denuclearising Iran by way of bunker busters – Tehran's air defences were taken out by Israel last year and Hezbollah has been decapitated and castrated – Trump seems to be bottling it.
The President publicly confirmed that he had asked Benjamin Netanyahu not to launch an attack while he was negotiating with the Ayatollah, amid days of speculation about a tense telephone call between the two men and American assessments that Israel may be preparing a strike of its own.
Jerusalem is deeply concerned that an impending Trump-Khamenei deal would take the threat of an assault by the United States off the table, while leaving Iran in a holding pattern that would allow the Ayatollah to advance his nuclear programme again when he's good and ready.
There are also serious worries about an interim deal that would offer Iran sanctions relief before a nuclear accord is reached, hosing billions of dollars into its coffers that may be used to rebuild Hezbollah and its other devastated assets. This would allow the Iranians breathing space to do what they do best: drag on the talks while pushing their agenda forward, quietly but steadily.
We have even seen growing reports of friction between Trump and Netanyahu, which is beginning to look rather like the 'daylight' famously placed by Biden between the United States and its beleaguered ally. It's all a far cry from the berserker rhetoric that Trump so loudly trumpeted before he took office. Has he been mugged by reality? Or is the 47th president all mouth and no trousers?
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
28 minutes ago
- Yahoo
Analysts assess the potential impact of Trump's surprise 50% steel tariffs
-- U.S. President Donald Trump unexpectedly announced on Friday that steel and aluminum tariffs will double to 50%. The move, set to come into effect on June 4, was unveiled during a campaign rally in Pennsylvania. It was later confirmed on TruthSocial and comes amid broader debates around U.S. industrial policy and foreign investment. Analysts are now evaluating the implications of this surprise decision, with most agreeing that the immediate domestic effects may be less severe than the broader geopolitical risks. JPMorgan's Tatsuya Maruyama said the direct impact on major Japanese steelmakers such as Nippon Steel Corp (TYO:5401), JFE Holdings, Inc. (TYO:5411), and Kobe Steel, Ltd. (TYO:5406) is expected to be limited, given that 'the U.S. accounts for about 4% of Japan's steel exports.' Maruyama pointed out in a Monday note that Nippon Steel and JFE export only about 1% of their total shipments to the U.S., while Kobe Steel exports about 3%. Still, he warned that 'rising global protectionism' is a growing concern, noting that a wave of anti-dumping measures and safeguards in regions like South Korea, the EU, and India could further strain global trade dynamics. 'If such countermeasures gain momentum, Japanese steel products may also be targeted and the export environment may worsen,' Maruyama continued. Meanwhile, analysts at BMO Capital Markets believe the sudden tariff hike could jolt domestic markets. 'The doubling of import tariffs, if maintained, is likely to create a panic in the market and trigger a restocking cycle that in our view has the potential to push prices >$1,000/st in the near-term,' the analysts said. However, they believe the spike would be temporary given macro uncertainty and seasonal demand trends. The broker upgraded Nucor (NYSE:NUE) to Outperform but downgraded Algoma Central (TSX:ALC), which it called 'a relative tariff loser.' The aluminum market may be more exposed, according to BMO. The U.S. covers only about 20% of its own aluminum consumption domestically, making it more vulnerable to supply disruptions. 'If tariffs do double, this is expected to put material upside pressure on the Midwest premium (MWP),' BMO wrote, estimating it could reach '$0.75/lb-plus' in theory, although higher aluminum cost will likely weigh on demand and thus offset some upside pressure. That said, the brokerage sees Century Aluminum (NASDAQ:CENX) as well positioned to benefit from a rise in the Midwest premium, while Alcoa (NYSE:AA) could see a negative impact of $1–2 per share, or 4–7%, due to its reliance on Canadian production. Still, BMO expects Alcoa may redirect some of its Canadian output to the EU market. Related articles Analysts assess the potential impact of Trump's surprise 50% steel tariffs Street Calls of the Week VIDEO: How to analyze a stock like a pro with the CEO of HF Foods
Yahoo
29 minutes ago
- Yahoo
1 Value Stock on Our Buy List and 2 to Approach with Caution
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues. Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here is one value stock with strong fundamentals and two best left ignored. Forward P/E Ratio: 14.5x Synonymous with "dad shoe", Skechers (NYSE:SKX) is a footwear company renowned for its comfortable, stylish, and affordable shoes for all ages. Why Is SKX Risky? Constant currency revenue growth has disappointed over the past two years and shows demand was soft Estimated sales growth of 7.4% for the next 12 months implies demand will slow from its two-year trend Poor free cash flow margin of 4.4% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends Skechers is trading at $62.04 per share, or 14.5x forward P/E. Dive into our free research report to see why there are better opportunities than SKX. Forward P/E Ratio: 9.9x Established in 1878, Mohawk Industries (NYSE:MHK) is a leading producer of floor-covering products for both residential and commercial applications. Why Are We Out on MHK? Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth ROIC of 3.5% reflects management's challenges in identifying attractive investment opportunities, and its decreasing returns suggest its historical profit centers are aging Diminishing returns on capital from an already low starting point show that neither management's prior nor current bets are going as planned At $100.61 per share, Mohawk Industries trades at 9.9x forward P/E. Check out our free in-depth research report to learn more about why MHK doesn't pass our bar. Forward P/E Ratio: 3.7x Pioneering treatments for a devastating childhood muscle-wasting disease that primarily affects boys, Sarepta Therapeutics (NASDAQ:SRPT) develops and commercializes RNA-targeted therapies and gene therapies for rare genetic disorders, primarily Duchenne muscular dystrophy. Why Are We Bullish on SRPT? Annual revenue growth of 51.3% over the last two years was superb and indicates its market share increased during this cycle Earnings per share grew by 38.8% annually over the last five years, massively outpacing its peers Cash burn has decreased over the last five years, showing the company is becoming a more self-sustaining business Sarepta Therapeutics's stock price of $37.50 implies a valuation ratio of 3.7x forward P/E. Is now the time to initiate a position? Find out in our full research report, it's free. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Sign in to access your portfolio


Boston Globe
35 minutes ago
- Boston Globe
Today in History: June 2, Queen Elizabeth II crowned
In 1886, 49-year-old President Grover Cleveland became the first president to get married in the White House, wedding 21-year-old Frances Folsom. Advertisement In 1924, Congress passed, and President Calvin Coolidge signed, the Indian Citizenship Act, a measure guaranteeing full American citizenship for all Native Americans born within US territorial limits. In 1941, baseball's 'Iron Horse,' Lou Gehrig, died in New York of the degenerative disease amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease; he was 37. Advertisement In 1953, Queen Elizabeth II was crowned at age 27 at a ceremony in London's Westminster Abbey, 16 months after the death of her father, King George VI. In 1966, US space probe Surveyor 1 landed on the moon and began transmitting detailed photographs of the lunar surface. In 1997, Timothy McVeigh was convicted of murder by a federal jury in the 1995 bombing of the Alfred P. Murrah Federal Building in Oklahoma City, which killed 168 people. (McVeigh would be sentenced to death and was executed in 2001.) In 1999, South Africans went to the polls in their second post-apartheid election, giving the African National Congress a decisive victory; retiring President Nelson Mandela was succeeded by Thabo Mbeki. In 2012, ousted Egyptian President Hosni Mubarak was sentenced to life in prison after a court convicted him on charges of complicity in the killing of protesters during the 2011 uprising that forced him from power. (Mubarak was later acquitted and freed in March 2017; he died in February 2020). In 2016, autopsy results revealed that musician Prince died of an accidental overdose of fentanyl, a powerful opioid painkiller.